Xintong Shi - Publications

Benefits of entecavir therapy in HBV-related hepatocellular carcinoma patients with compensated cirrhosis after hepatectomy: A ten-year retrospective cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: October 24, 2024

HBcrAg is associated with prognosis of hepatitis B virus-related hepatocellular carcinoma in patients after hepatectomy undergoing antiviral therapy.

Journal: International journal of cancer

Published: May 23, 2024

Prognostic analysis and risk assessment based on RNA editing in hepatocellular carcinoma.

Journal: Journal of applied genetics

Published: November 03, 2023

Machine learning radiomics to predict the early recurrence of intrahepatic cholangiocarcinoma after curative resection: A multicentre cohort study.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 18, 2022

Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 08, 2022

Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.

Journal: Frontiers in immunology

Published: August 02, 2022

Comprehensive Evaluation and Application of a Novel Method to Isolate Cell-Free DNA Derived From Bile of Biliary Tract Cancer Patients.

Journal: Frontiers in oncology

Published: March 08, 2022

The Chemopreventive Role of β-Elemene in Cholangiocarcinoma by Restoring PCDH9 Expression.

Journal: Frontiers in oncology

Published: February 12, 2022